Recombinant production and purification of the human protein Tau

Publication date

2018-12-01

Authors

Ferrari, LucaISNI 0000000505993192
Rüdiger, Stefan G.D.ISNI 0000000394040769

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

cc_by

Abstract

Tau protein is a microtubule-stabilising protein whose aggregation is linked to Alzheimer's Disease and other forms of dementia. Tau biology is at the heart of cytoskeletal dynamics and neurodegenerative mechanisms, making it a crucial protein to study. Tau purification, however, is challenging as Tau is disordered, which makes it difficult to produce in recombinant system and is degradation-prone. It is thus challenging to obtain pure and stable preparations of Tau. Here, we present a fast and robust protocol to purify Tau recombinantly in Escherichia coli. Our protocol allows purifying Tau either tag-less or FLAG-tagged at its N-terminus, and Tau fragments of interest. By exploiting a cleavable affinity tag and two anion exchange columns, we obtained Tau preparations of high purity, stable and suitable for in vitro studies, including aggregation experiments that resemble neurodegenerative processes.

Keywords

Alzheimer’s disease, neurodegeneration, protein aggregation, protein purification/intrinsically disordered protein, protein aggregate, recombinant protein, tau protein, amino acid sequence, biosynthesis, chemistry, genetic engineering, genetics, human, isolation and purification, mutation, procedures

Citation

Ferrari, L & Rüdiger, S G D 2018, 'Recombinant production and purification of the human protein Tau', Protein Engineering, Design and Selection, vol. 31, no. 12, pp. 447-455. https://doi.org/10.1093/protein/gzz010